Autosomal dominant osteopetrosis.
Polgreen LE, Imel EA, Econs MJ.
Bone. 2023 May;170:116723. doi: 10.1016/j.bone.2023.116723. Epub 2023 Feb 28.
Autosomal Dominant Osteopetrosis.
Meira T, Soares-Fernandes JP.
N Engl J Med. 2022 Sep 29;387(13):e27. doi: 10.1056/NEJMicm2202055. Epub 2022 Sep 24.
Osteopetrosis.
Stark Z, Savarirayan R.
Orphanet J Rare Dis. 2009 Feb 20;4:5. doi: 10.1186/1750-1172-4-5.
Autosomal dominant osteopetrosis revisited: lessons from recent studies.
Bollerslev J, Henriksen K, Nielsen MF, Brixen K, Van Hul W.
Eur J Endocrinol. 2013 Jul 13;169(2):R39-57. doi: 10.1530/EJE-13-0136. Print 2013 Aug.
Autosomal dominant osteopetrosis.
Bollerslev J, Mosekilde L.
Clin Orthop Relat Res. 1993 Sep;(294):45-51.
Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.
Bollerslev J.
Endocr Rev. 1989 Feb;10(1):45-67. doi: 10.1210/edrv-10-1-45.
Autosomal-dominant osteopetrosis: an incidental finding.
Rajathi M, Austin RD, Mathew P, Bharathi CS, Srivastava KC.
Indian J Dent Res. 2010 Oct-Dec;21(4):611-4. doi: 10.4103/0970-9290.74234.
Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.
Jodeh W, Katz AJ, Hart M, Warden SJ, Niziolek P, Alam I, Ing S, Polgreen LE, Imel EA, Econs MJ.
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1726-1732. doi: 10.1210/clinem/dgae040.
CLCN7-Related Osteopetrosis.
Sobacchi C, Villa A, Schulz A, Kornak U.
2007 Feb 12 [updated 2022 Jan 20]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Autosomal dominant osteopetrosis type II resulting from a de novo mutation in the CLCN7 gene: A case report.
Song XL, Peng LY, Wang DW, Wang H.
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.
